在肝癌中利用氨酸积累:结合基因组数据和药物向
Swamy R Adapa1,2, Pravin Meshram2, Abdus Sami3
1USF Genomics Program, Center for Global Health and Infectious Diseases, College of Public Health, University of South Florida, Tampa, FL 33612, USA.
Biomolecules
|August 29, 2024
概括
癌细胞破坏了肝脏的血红蛋白生产,导致有毒的中间体积聚. 这个这个这个这个这个
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
背景情况:
- 肝脏是血红素生物合成的核心,对新陈代谢和排毒至关重要.
- 精确的血生产控制可以防止有毒中间体在健康的肝脏中积累.
- 癌症破坏了这种平衡,导致"氨酸过量"和中间积累,可能有助于瘤存活.
研究的目的:
- 在健康和癌症的人类肝脏中研究血红素和氨酸代谢.
- 了解血红素中间积累在肝癌进展中的作用.
- 通过分析基因表达模式来确定潜在的治疗点.
主要方法:
- 利用了人类肝脏的主要转录组学.
- 使用单细胞RNA测序 (scRNAseq).
- 进行了体外药物协同作用实验.
主要成果:
- 健康的肝脏保持强大的血生物合成ETC和细胞染色体P450功能.
- 肝癌呈现出改变的血合成,减少细胞染色体P450表达和中间积累.
- 在癌症中,对ETC的血红素供应保持或增加,这表明代谢转移.
- 异常的氨酸代谢基因表达与侵袭性癌症的生存率较差有关.
结论:
- 肝癌诱导"氨酸过量",积累有毒的血中间体.
- 这种新陈代谢的重新连接优先考虑对ETC的血供应,而不是药物代谢.
- 向氨酸代谢是一种潜在的肝癌治疗策略.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


